Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America
Open Access
- 1 February 2005
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (Supplement) , S1-S84
- https://doi.org/10.1086/427295
Abstract
In 2001, CDC, the National Institutes of Health, and the Infectious Diseases Society of America convened a working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opportunistic infections to serve as a companion to the Guidelines for Prevention of Opportunistic Infections Among HIV-Infected Persons. In recognition of unique considerations related to HIV infection among infants, children, and adolescents, a separate pediatric working group was established. Because HIV-infected women coinfected with opportunistic pathogens might be more likely to transmit these infections to their infants than women without HIV infection, guidelines for treating opportunistic pathogens among children should consider treatment of congenitally acquired infections among both HIV-exposed but uninfected children and those with HIV infection. In addition, the natural history of opportunistic infections among HIV-infected children might differ from that among adults. Compared with opportunistic infections among HIV-infected adults, which are often caused by reactivation of pathogens acquired before HIV infection when host immunity was intact, opportunistic infections among children often reflect primary acquisition of the pathogen and, among children with perinatal HIV infection, infection acquired after HIV infection has been established and begun to compromise an already immature immune system. Laboratory diagnosis of opportunistic infections can be more difficult with children. Finally, treatment recommendations should consider differences between adults and children in terms of drug pharmacokinetics, dosing, formulations, administration, and toxicities. This report focuses on treatment of opportunistic infections that are common in HIV-exposed and infected infants, children, and adolescents in the United States.Keywords
This publication has 381 references indexed in Scilit:
- Guide to Development of Practice GuidelinesClinical Infectious Diseases, 2001
- Does delivery improve maternal condition in the respiratory-compromised gravida?Published by Wolters Kluwer Health ,1998
- Centers for Disease Control and Prevention guidelines for congenital syphilisThe Journal of Pediatrics, 1996
- Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virusThe Journal of Pediatrics, 1996
- Perinatal infection and persistence of human papillomavirus types 16 and 18 in infantsJournal of Medical Virology, 1995
- Response to interferon therapy in children with chronic hepatitis CThe Journal of Pediatrics, 1995
- Use of polymerase chain reaction for improved diagnosis of tuberculosis in childrenThe Journal of Pediatrics, 1995
- Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infectionThe Journal of Pediatrics, 1994
- Safety and pharmacokinetics of fluconazole in children with neoplastic diseasesThe Journal of Pediatrics, 1992
- Cervicovaginal human papillomavirus infection in suburban adolescents and young adultsThe Journal of Pediatrics, 1991